Evidence map›Paper›PMID 36914250›Full record

ArticleHeart (British Cardiac Society)2023

Sex-specific trajectories of molecular cardiometabolic traits from childhood to young adulthood.

Linda M O'Keeffe, Kate Tilling, Joshua A Bell, Patrick T Walsh, Matthew A Lee, Deborah A Lawlor, George Davey Smith, Patricia M Kearney

Abstract read
In one paragraph

Article in Heart (British Cardiac Society), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Linda M O'KeeffeSchool of Public Health, University College Cork, Cork, Ireland linda.okeeffe@ucc.ie linda.okeeffe@bristol.ac.uk.ORCID 0000-0002-0003-0774
Kate TillingMRC Integrative Epidemiology Unit at the University of Bristol, University of Bristol, Bristol, UK.
Joshua A BellMRC Integrative Epidemiology Unit at the University of Bristol, University of Bristol, Bristol, UK.
Patrick T WalshSchool of Public Health, University College Cork, Cork, Ireland.ORCID 0000-0003-2628-987X
Matthew A LeeMRC Integrative Epidemiology Unit at the University of Bristol, University of Bristol, Bristol, UK.
Deborah A LawlorMRC Integrative Epidemiology Unit at the University of Bristol, University of Bristol, Bristol, UK.ORCID 0000-0002-6793-2262
George Davey SmithMRC Integrative Epidemiology Unit at the University of Bristol, University of Bristol, Bristol, UK.
Patricia M KearneySchool of Public Health, University College Cork, Cork, Ireland.ORCID 0000-0001-9599-3540

Funding

British Heart Foundation CH/F/20/90003Department of Health NF-0616-10102Medical Research Council G9815508Medical Research Council MC_PC_15018Medical Research Council MC_PC_19009Medical Research Council MC_UU_00011/1Medical Research Council MC_UU_00011/3Medical Research Council MC_UU_00011/6Medical Research Council MC_UU_00032/1Medical Research Council MC_UU_12013/1Medical Research Council MR/R502340/1Wellcome TrustWellcome Trust 204813/Z/16/ZWellcome Trust 217065/Z/19/Z
6 · The paper itself

Abstract

backgroundThe changes which typically occur in molecular causal risk factors and predictive biomarkers for cardiometabolic diseases across early life are not well characterised.

methodsWe quantified sex-specific trajectories of 148 metabolic trait concentrations including various lipoprotein subclasses from age 7 years to 25 years. Data were from 7065 to 7626 offspring (11 702 to14 797 repeated measures) of the Avon Longitudinal Study of Parents and Children birth cohort study. Outcomes were quantified using nuclear magnetic resonance spectroscopy at 7, 15, 18 and 25 years. Sex-specific trajectories of each trait were modelled using linear spline multilevel models.

resultsFemales had higher very-low-density lipoprotein (VLDL) particle concentrations at 7 years. VLDL particle concentrations decreased from 7 years to 25 years with larger decreases in females, leading to lower VLDL particle concentrations at 25 years in females. For example, females had a 0.25 SD (95% CI 0.20 to 0.31) higher small VLDL particle concentration at 7 years; mean levels decreased by 0.06 SDs (95% CI -0.01 to 0.13) in males and 0.85 SDs (95% CI 0.79 to 0.90) in females from 7 years to 25 years, leading to 0.42 SDs (95% CI 0.35 to 0.48) lower small VLDL particle concentrations in females at 25 years. Females had lower high-density lipoprotein (HDL) particle concentrations at 7 years. HDL particle concentrations increased from 7 years to 25 years with larger increases among females leading to higher HDL particle concentrations in females at 25 years.

conclusionChildhood and adolescence are important periods for the emergence of sex differences in atherogenic lipids and predictive biomarkers for cardiometabolic disease, mostly to the detriment of males.

Indexed as

AtherosclerosisLipoproteinsAdolescentAdultBiomarkersChildCohort StudiesFemaleHumansLongitudinal StudiesMaleYoung AdultBiomarkersLipoproteinsMetabolic Diseases

Identifiers

PMID36914250
PMCPMC10176380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.